ZIVO Teams With Animal Health Leader on Poultry Biologics
Slice of Agriculture Team
06/27/2025
Key highlights
- ZIVO partners with top animal health firm to advance poultry biologics
- Two funded studies to validate immune-enhancing compounds
- Targeting coccidiosis and major viral diseases in poultry
- Potential for expansion into other livestock and companion animals
- Focus on non-antibiotic, immune-modulating therapies
Source: Business Wire
Notable Quote
“ This collaboration supports our strategy to partner with a major animal health company that brings scientific expertise and R&D infrastructure to advance our innovations to global markets efficiently and at scale. Adding ZIVO’s therapeutic products to their portfolio would represent an entirely new market for our partner, and the significant prior work we’ve done provides high confidence for success. ”
John Payne, Chairman and CEO at ZIVO Bioscience
Why This Matters
This partnership positions ZIVO Bioscience to potentially transform animal health through novel, algae-derived immunotherapies that complement current vaccination strategies. With fully funded studies targeting both parasitic and viral poultry diseases, the initiative could reduce antibiotic reliance, improve livestock health outcomes, and open new markets for sustainable, biologic-based solutions across the animal agriculture sector.
